{"pmid":32478957,"title":"Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.","text":["Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.","The coronavirus pandemic has resulted in the need for rapid assessment of resource utilization within our hospital systems. Specifically, the overwhelming need for intensive care unit (ICU) beds within epicenters of the pandemic has created a need for consideration as to how acute coronary syndrome cases, and specifically ST-elevation myocardial infarction (STEMI) patients, are managed postprocedure. While most patients in the United States continue to be managed in coronary care units after primary percutaneous coronary intervention, there is a robust literature regarding the ability to triage STEMI patients safely and efficiently with low-risk features to non-ICU beds. We review the various risk scores for STEMI triage and the data supporting their usage. In summary, these findings support an approach to low-risk STEMI triage that does not come at the expense of quality patient care or outcomes, where up to two-thirds of patients with STEMI may be able to be safely managed without ICU-level care.","Catheter Cardiovasc Interv","Lopez, John J","Ebinger, Joseph E","Allen, Sorcha","Yildiz, Mehmet","Henry, Timothy D","32478957"],"abstract":["The coronavirus pandemic has resulted in the need for rapid assessment of resource utilization within our hospital systems. Specifically, the overwhelming need for intensive care unit (ICU) beds within epicenters of the pandemic has created a need for consideration as to how acute coronary syndrome cases, and specifically ST-elevation myocardial infarction (STEMI) patients, are managed postprocedure. While most patients in the United States continue to be managed in coronary care units after primary percutaneous coronary intervention, there is a robust literature regarding the ability to triage STEMI patients safely and efficiently with low-risk features to non-ICU beds. We review the various risk scores for STEMI triage and the data supporting their usage. In summary, these findings support an approach to low-risk STEMI triage that does not come at the expense of quality patient care or outcomes, where up to two-thirds of patients with STEMI may be able to be safely managed without ICU-level care."],"journal":"Catheter Cardiovasc Interv","authors":["Lopez, John J","Ebinger, Joseph E","Allen, Sorcha","Yildiz, Mehmet","Henry, Timothy D"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478957","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/ccd.28993","keywords":["pci","stemi","acute coronary syndrome","pandemic"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1668437835163631616,"score":9.490897,"similar":[{"pmid":32471712,"title":"Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic.","text":["Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic.","The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy.","Cardiovasc Revasc Med","Yerasi, Charan","Case, Brian C","Forrestal, Brian J","Chezar-Azerrad, Chava","Hashim, Hayder","Ben-Dor, Itsik","Satler, Lowell F","Mintz, Gary S","Waksman, Ron","32471712"],"abstract":["The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy."],"journal":"Cardiovasc Revasc Med","authors":["Yerasi, Charan","Case, Brian C","Forrestal, Brian J","Chezar-Azerrad, Chava","Hashim, Hayder","Ben-Dor, Itsik","Satler, Lowell F","Mintz, Gary S","Waksman, Ron"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471712","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.carrev.2020.05.027","keywords":["covid-19","fibrinolytics","primary percutaneous coronary intervention","stemi"],"topics":["Prevention"],"weight":1,"_version_":1668255193421053952,"score":461.76166},{"pmid":32467422,"title":"Effects of the COVID-19 Pandemic on the Management of Patients With ST-Elevation Myocardial Infarction in a Tertiary Cardiovascular Center.","text":["Effects of the COVID-19 Pandemic on the Management of Patients With ST-Elevation Myocardial Infarction in a Tertiary Cardiovascular Center.","BACKGROUND: In the COVID-19 pandemic, the appropriate reperfusion strategy in patients with ST-segment elevation myocardial infarction (STEMI) is unclear. METHODS: This retrospective single-center study consecutively enrolled patients who presented with STEMI and scheduled for primary percutaneous coronary intervention (PPCI) during the outbreak of COVID- 19. Due to the delay in the reporting of the PCR test results, our postprocedural triage regarding COVID-19, followed by the isolation strategy, was based on lung CT scan results. RESULTS: Forty-eight patients with STEMI referred to our center. PPCI was done for 44 (91%) of these patients. The mean symptom-to-device time was 490.93 +/- 454.608 minutes, and the mean FMC-to-device time was and 154.12 +/- 36.27 minutes. Nine (18%) patients with STEMI were diagnosed as having typical/indeterminate features indicating COVID-19 involvement. During hospitalization, 1 (2.0%) patient died of cardiogenic shock. The study population was followed for 35.9 +/- 12.7 days. Two patients expired in another centers due to COVID-19. No CCL staff members were infected by COVID-19 during the study period. CONCLUSIONS: Our small report indicates that by taking the recommended safety measures and using appropriate PPE, we can continue PPCI as the main reperfusion strategy safely and effectively.","Crit Pathw Cardiol","Firouzi, Ata","Baay, Mohammadreza","Mazayanimonfared, Azadeh","Pouraliakbar, Hamidreza","Sadeghipour, Parham","Noohi, Feridoun","Maleki, Majid","Peighambari, Mohamad Mehdi","Kiavar, Majid","Abdi, Seifollah","Maadani, Mohsen","Shakerian, Farshad","Zahedmehr, Ali","Kiani, Reza","Ansari, Mohammad Javad Alemzadeh","Rashidinejad, Alireza","Hosseini, Zahra","32467422"],"abstract":["BACKGROUND: In the COVID-19 pandemic, the appropriate reperfusion strategy in patients with ST-segment elevation myocardial infarction (STEMI) is unclear. METHODS: This retrospective single-center study consecutively enrolled patients who presented with STEMI and scheduled for primary percutaneous coronary intervention (PPCI) during the outbreak of COVID- 19. Due to the delay in the reporting of the PCR test results, our postprocedural triage regarding COVID-19, followed by the isolation strategy, was based on lung CT scan results. RESULTS: Forty-eight patients with STEMI referred to our center. PPCI was done for 44 (91%) of these patients. The mean symptom-to-device time was 490.93 +/- 454.608 minutes, and the mean FMC-to-device time was and 154.12 +/- 36.27 minutes. Nine (18%) patients with STEMI were diagnosed as having typical/indeterminate features indicating COVID-19 involvement. During hospitalization, 1 (2.0%) patient died of cardiogenic shock. The study population was followed for 35.9 +/- 12.7 days. Two patients expired in another centers due to COVID-19. No CCL staff members were infected by COVID-19 during the study period. CONCLUSIONS: Our small report indicates that by taking the recommended safety measures and using appropriate PPE, we can continue PPCI as the main reperfusion strategy safely and effectively."],"journal":"Crit Pathw Cardiol","authors":["Firouzi, Ata","Baay, Mohammadreza","Mazayanimonfared, Azadeh","Pouraliakbar, Hamidreza","Sadeghipour, Parham","Noohi, Feridoun","Maleki, Majid","Peighambari, Mohamad Mehdi","Kiavar, Majid","Abdi, Seifollah","Maadani, Mohsen","Shakerian, Farshad","Zahedmehr, Ali","Kiani, Reza","Ansari, Mohammad Javad Alemzadeh","Rashidinejad, Alireza","Hosseini, Zahra"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467422","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/HPC.0000000000000228","topics":["Prevention"],"weight":1,"_version_":1668167110021349376,"score":457.9298},{"pmid":32432162,"title":"Pharmaco-invasive Therapy for STEMI in a Patient with COVID-19: A Case Report.","text":["Pharmaco-invasive Therapy for STEMI in a Patient with COVID-19: A Case Report.","Coronavirus disease 2019 (COVID-19) is a pandemic that started in the Wuhan province of China in December 2019. It is associated with increased morbidity and mortality mainly due to severe acute respiratory syndrome 2 (SARS-Cov-2). Cardiac manifestations related to COVID-19 include demand ischemia, fulminant myocarditis, myocardial infarction and arrhythmias. In this report, we present a case of ST-segment elevation myocardial infarction (STEMI) in a 68-year-old man with COVID-19 who initially presented with chest pain and shortness of breath. Patient's STEMI was managed with pharmaco-invasive strategy with tissue plasminogen activator (t-PA). He then developed acute hypoxic respiratory failure that was managed in the intensive care unit (ICU), together with multi-organ failure from which the patient died 2 days after presentation. Although the pathophysiologic mechanisms of STEMI in COVID-19 patients has not been clearly established, we hypothesize that interrelated pathogenetic factors, that we highlight in this report, can play a role in the development of STEMI, including plaque rupture secondary to systemic inflammation, increased pro-coagulants, endothelial dysfunction, impaired fibrinolysis and impaired oxygen utilization leading to demand/supply mismatch and myocardial ischemia.","Am J Med Case Rep","Kariyanna, Pramod Theetha","Hossain, Naseem","Jayarangaiah, Apoorva","Hossain, Nimrah A","Francois, Jonathan Christopher","Marmur, Jonathan D","Salifu, Moro O","McFarlane, Samy I","32432162"],"abstract":["Coronavirus disease 2019 (COVID-19) is a pandemic that started in the Wuhan province of China in December 2019. It is associated with increased morbidity and mortality mainly due to severe acute respiratory syndrome 2 (SARS-Cov-2). Cardiac manifestations related to COVID-19 include demand ischemia, fulminant myocarditis, myocardial infarction and arrhythmias. In this report, we present a case of ST-segment elevation myocardial infarction (STEMI) in a 68-year-old man with COVID-19 who initially presented with chest pain and shortness of breath. Patient's STEMI was managed with pharmaco-invasive strategy with tissue plasminogen activator (t-PA). He then developed acute hypoxic respiratory failure that was managed in the intensive care unit (ICU), together with multi-organ failure from which the patient died 2 days after presentation. Although the pathophysiologic mechanisms of STEMI in COVID-19 patients has not been clearly established, we hypothesize that interrelated pathogenetic factors, that we highlight in this report, can play a role in the development of STEMI, including plaque rupture secondary to systemic inflammation, increased pro-coagulants, endothelial dysfunction, impaired fibrinolysis and impaired oxygen utilization leading to demand/supply mismatch and myocardial ischemia."],"journal":"Am J Med Case Rep","authors":["Kariyanna, Pramod Theetha","Hossain, Naseem","Jayarangaiah, Apoorva","Hossain, Nimrah A","Francois, Jonathan Christopher","Marmur, Jonathan D","Salifu, Moro O","McFarlane, Samy I"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32432162","source":"PubMed","week":"202021|May 18 - May 24","keywords":["covid-19","pharmaco-invasive therapy","st-segment elevation myocardial infarction (stemi)"],"locations":["Wuhan","China","Pharmaco"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1667342288321249280,"score":448.80945},{"pmid":32490506,"title":"Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.","text":["Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.","Coronavirus disease 2019 (COVID-19) is a recently recognised pandemic spreading rapidly from Wuhan, Hubei, to other provinces in China and to many countries around the world. The number of COVID-19-related deaths is steadily increasing. Acute ST-segment elevation myocardial infarction (STEMI) is a disease with high morbidity and mortality rates, and primary percutaneous coronary intervention is usually recommended for the treatment. A patient with diabetes mellitus and hypertension for five years was admitted to the emergency unit with symptoms of fever, cough and dyspnoea. These symptoms were consistent with viral pneumonia and a COVID PCR test was performed, which tested positive three days later. The patient had chest pain on the eighth day of hospitalisation. On electrocardiography, simultaneous acute inferior and anterior STEMI were identified. High levels of stress and increased metabolic demand in these patients may lead to concomitant thrombosis of different coronary arteries, presenting with two different STEMIs.","Cardiovasc J Afr","Yolcu, Mustafa","Gunesdogdu, Fusun","Bektas, Metin","Bayirli, Derya Turan","Serefhanoglu, Kivanc","32490506"],"abstract":["Coronavirus disease 2019 (COVID-19) is a recently recognised pandemic spreading rapidly from Wuhan, Hubei, to other provinces in China and to many countries around the world. The number of COVID-19-related deaths is steadily increasing. Acute ST-segment elevation myocardial infarction (STEMI) is a disease with high morbidity and mortality rates, and primary percutaneous coronary intervention is usually recommended for the treatment. A patient with diabetes mellitus and hypertension for five years was admitted to the emergency unit with symptoms of fever, cough and dyspnoea. These symptoms were consistent with viral pneumonia and a COVID PCR test was performed, which tested positive three days later. The patient had chest pain on the eighth day of hospitalisation. On electrocardiography, simultaneous acute inferior and anterior STEMI were identified. High levels of stress and increased metabolic demand in these patients may lead to concomitant thrombosis of different coronary arteries, presenting with two different STEMIs."],"journal":"Cardiovasc J Afr","authors":["Yolcu, Mustafa","Gunesdogdu, Fusun","Bektas, Metin","Bayirli, Derya Turan","Serefhanoglu, Kivanc"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32490506","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10-5830-CVJA-2020-016","keywords":["covid-19","acute anterior wall myocardial infarction","acute inferior wall myocardial infarction"],"locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668623433636773889,"score":416.9848},{"pmid":32337148,"pmcid":"PMC7179991","title":"Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.","text":["Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.","Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity is high in these patients with cardiovascular involvement. Acute ST-elevation myocardial infarction (STEMI) is a medical emergency which needs immediate coronary re-perfusion for better patient outcomes. Here we present a patient who presented to the emergency room with acute STEMI and later tested positive for COVID-19. She was successfully treated with coronary revascularization and stent placement, and remains on the ventilator to date as she quickly developed acute respiratory distress syndrome. We need more research in Covid-19 patients with cardiovascular involvement for early diagnosis, prevention of exposure to health care workers and effective treatment.","Cureus","Siddamreddy, Suman","Thotakura, Ramakrishna","Dandu, Vasuki","Kanuru, Sruthi","Meegada, Sreenath","32337148"],"abstract":["Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity is high in these patients with cardiovascular involvement. Acute ST-elevation myocardial infarction (STEMI) is a medical emergency which needs immediate coronary re-perfusion for better patient outcomes. Here we present a patient who presented to the emergency room with acute STEMI and later tested positive for COVID-19. She was successfully treated with coronary revascularization and stent placement, and remains on the ventilator to date as she quickly developed acute respiratory distress syndrome. We need more research in Covid-19 patients with cardiovascular involvement for early diagnosis, prevention of exposure to health care workers and effective treatment."],"journal":"Cureus","authors":["Siddamreddy, Suman","Thotakura, Ramakrishna","Dandu, Vasuki","Kanuru, Sruthi","Meegada, Sreenath"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337148","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.7759/cureus.7782","keywords":["acute respiratory distress syndrome","atypical covid","covid-19","stemi"],"topics":["Case Report"],"weight":1,"_version_":1666138494275158017,"score":409.6198}]}